VISLUCI
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Oct 2025)
What this means for you
This application is over — abandoned 17 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97273771
- Mark type
- Stylized text
- Filed
- 18 Feb 2022
- Published for opposition
- 04 Apr 2023
- Abandoned
- 17 Oct 2025
- Attorney of record
- CONNIE ELLERBACH
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic agents, preparations, and substances for medical purposes; Imaging and therapeutic agents for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; Preparations and substances for medical purposes for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; None of the foregoing for detecting, diagnosing, or treating diseases originating in the eye, with the exception of melanoma; medical diagnostic reagents; reagents for medical use; imaging and detection agents for diagnosing and monitoring cancer, and oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders
- Class 042 — Scientific and technological services: Medical research; scientific research; product research and development; product development in the field of the detection, location, and treatment of diseases; design and development of therapies, diagnostic agents, imaging agents, and medical devices for detecting, locating, and treating cancer and other diseases
Owner
- Blaze Bioscience, Inc., Seattle, WA, US
- Blaze Bioscience, Inc., Seattle, WA, US
Prosecution history
- 17 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 17 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2024 — SOU EXTENSION 2 GRANTED
- 18 Dec 2024 — SOU EXTENSION 2 FILED
- 18 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jul 2024 — SOU EXTENSION 1 GRANTED
- 10 Jul 2024 — SOU EXTENSION 1 FILED
- 10 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Dec 2023 — TTAB RELEASE CASE TO TRADEMARKS
- 16 Dec 2023 — OPPOSITION TERMINATED NO. 999999
- 16 Dec 2023 — OPPOSITION DISMISSED NO. 999999
- 01 Aug 2023 — OPPOSITION INSTITUTED NO. 999999